These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2076674

  • 1. Short course chemotherapy for pulmonary tuberculosis in routine service in Kenya.
    Babu Swai O, Aluoch JA, Githui W, Darbyshire JH.
    East Afr Med J; 1990 Nov; 67(11):748-55. PubMed ID: 2076674
    [Abstract] [Full Text] [Related]

  • 2. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W.
    Rev Mal Respir; 1986 Nov; 3(2):73-85. PubMed ID: 3726263
    [Abstract] [Full Text] [Related]

  • 3. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 5. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K, Kawabata S, Masuda N.
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [Abstract] [Full Text] [Related]

  • 6. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 7. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.
    Trop Med Int Health; 2005 Nov 11; 10(11):1090-8. PubMed ID: 16262733
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct 11; 78(4):330-6. PubMed ID: 6386028
    [Abstract] [Full Text] [Related]

  • 12. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK.
    Int J Tuberc Lung Dis; 1999 Feb 11; 3(2):126-32. PubMed ID: 10091877
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
    Mazouni L, Tazir M, Boulahbal F, Chaulet P.
    Rev Mal Respir; 1985 Feb 11; 2(4):209-14. PubMed ID: 3937189
    [Abstract] [Full Text] [Related]

  • 15. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM, Bakare NA, Onadeko BO.
    Afr J Med Med Sci; 2000 Mar 11; 29(1):51-3. PubMed ID: 11379469
    [Abstract] [Full Text] [Related]

  • 16. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE, Zierski M, Graczyk J, Bek E, Farer LS.
    Eur J Respir Dis; 1986 Jan 11; 68(1):12-8. PubMed ID: 3512281
    [Abstract] [Full Text] [Related]

  • 17. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul 11; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 18. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.
    Int J Tuberc Lung Dis; 2002 Oct 11; 6(10):858-64. PubMed ID: 12365571
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of unfixed continuation phase short-course chemotherapy].
    Xiao C, Fu Y, Li Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec 11; 20(6):358-60. PubMed ID: 10374447
    [Abstract] [Full Text] [Related]

  • 20. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 11; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.